SPONDYLOLYSIS

This adverse event was reported 188 times

SPONDYLOLYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD38-directed Cytolytic Antibody [EPC] 8 0.0014
1 Calcitonin [EPC] 2 0.0006
2 Pyrethroid [EPC] 1 0.0006
3 Provitamin D2 Compound [EPC] 12 0.0004
4 mu-Opioid Receptor Agonist [EPC] 1 0.0003
5 Vitamin D2 Analog [EPC] 2 0.0003
6 Quinolone Antimicrobial [EPC] 2 0.0002
7 Nitrofuran Antibacterial [EPC] 3 0.0002
8 Adenosine Receptor Agonist [EPC] 1 0.0001
9 Cannabinoid [EPC] 1 0.0001
See all drug classes enriched for association with SPONDYLOLYSIS